# Karyopharm Therapeutics Inc.: Form 8-K, filed May 29, 2025

- Company: [Karyopharm Therapeutics Inc.](/companies/kpti.md) (CIK 1503802)
- Form: 8-K
- Filed: 2025-05-29
- Accepted by EDGAR: May 29, 2025, 16:28 ET
- Period: 2025-05-28
- Accession: 0000950170-25-079009
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1503802/000095017025079009/kpti-20250528.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1503802/000095017025079009/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1503802/000095017025079009/kpti-20250528.htm

Filed May 29, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-079009. Last ingested by Listed: Nov 3, 2026, 06:05 ET. No prices; not investment advice.